Uncovering Lucrative Low-Competition Generic Drug Opportunities

In the ever-evolving pharmaceutical landscape, savvy businesses are constantly on the lookout for untapped markets and lucrative opportunities. One area that has garnered significant attention is the realm of low-competition generic drugs. These are off-patent medications that, for various reasons, have yet to attract a significant number of generic manufacturers, creating a potential goldmine for


Maximizing ROI with Branded Generics: A Comprehensive Guide

Branded generics are generic drugs that are marketed under a brand name by the manufacturer. These products contain the same active ingredients as their brand-name counterparts but are typically sold at a lower price point. Branded generics can be an attractive option for both consumers and pharmaceutical companies, offering cost savings while leveraging brand recognition.

landscape mountains field trees

A Practical Guide to FtO Analysis for Drug Repurposing Ventures

A recent whitepaper by Hermann Mucke summarizes the steps to performing an FTO for drug repurposing: Overview An FtO analysis determines if a new product or process can proceed without infringing third-party intellectual property (IP) rights, especially patents. It is crucial for drug repurposing projects involving known compounds that may still be patent-protected. Basic Principles


Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies

The article “The devil is in the divisional: an analysis of divisional patents, deadlines, declarations and suggestions for future practice” by Mieke Filler provides a comprehensive analysis of the strategic use of divisional patents in the pharmaceutical sector to delay generic and biosimilar market entry. Key Points Citations:[1][2][3][4][5][6]

a close up shot of a person taking medicine from a bottle

Innovative Approaches to Extend the Life of Drug Patents

Pharmaceutical companies employ various strategies to extend the commercial life and patent protection of successful drugs. Here are some key approaches with examples: New Formulations One common strategy is to develop and patent new formulations of the existing drug compound to provide benefits like reduced dosing frequency, easier administration, improved bioavailability, or reduced side effects.


Crucial Insights on Patent Litigation Strategies in Pharma Industry

In the “Patent Effect” podcast, Mustafa introduces his guest, Hakan Yum, the IP Director of Exrain Pharma, based in Sweden. The focus of the discussion is on patent litigation strategies within the pharmaceutical industry, particularly concerning biosimilars versus generics and the complexities involved. Hakan begins by distinguishing between generics, typically small-molecule drugs, and biosimilars, which

person holding smartphone with blood sugar level on screen

Underutilized Opportunities: Exploring Patent Term Extensions for Medical Devices

In a recent study published in the Expert Review of Medical Devices, researchers investigated the utilization of patent term extensions (PTEs) to extend regulatory timeframes for medical devices in the United States. Here are the key takeaways from their findings: Key Points: Overall, the study provides valuable insights into the evolving landscape of PTE utilization


Innovative Strategies in Drug Repurposing

Drug repurposing, or identifying new therapeutic uses for existing drugs, is gaining significant momentum as a promising approach to accelerate drug development and reduce costs. This book chapter provides a comprehensive overview of the principles, strategies, and real-world examples of successful drug repurposing efforts. The chapter highlights several compelling advantages of drug repurposing over traditional

DrugPatentWatch - Make Better Decisions
Scroll to Top